Related Experiment Video
Updated: May 5, 2026
08:01
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
6.9K
Translating molecular discoveries into new therapies for atherosclerosis
Daniel J Rader1, Alan Daugherty
1Cardiovascular Institute and Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, 654 BRBII/III, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104, USA. rader@mail.med.upenn.edu
Nature
|February 22, 2008
Summary
Atherosclerosis, arterial wall thickening, causes major diseases. Targeting lipoproteins and the renin-angiotensin-aldosterone system shows therapeutic benefits for atherosclerotic cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Pathology
- Medical Research
Background:
- Atherosclerosis, characterized by arterial wall thickening, is a primary cause of global mortality from coronary artery and cerebrovascular diseases.
- Lipoproteins and the renin-angiotensin-aldosterone system are implicated in atherosclerotic cardiovascular disease pathogenesis.
- Understanding risk factors like hypertension, dyslipidemia, and diabetes is crucial for managing atherosclerosis.
Purpose of the Study:
- To review the role of lipoproteins and the renin-angiotensin-aldosterone system in atherosclerosis.
- To explore the contribution of major risk factors to atherosclerotic disease.
- To identify novel therapeutic targets based on molecular pathogenesis.
Main Methods:
- Literature review of clinical trials and research studies.
- Analysis of the impact of lipoproteins and the renin-angiotensin-aldosterone system.
- Examination of the molecular mechanisms underlying atherosclerotic plaque development.
Main Results:
- Clinical trials confirm the benefit of targeting specific lipoproteins.
- Interventions targeting the renin-angiotensin-aldosterone system demonstrate efficacy.
- Research is uncovering new therapeutic targets by elucidating molecular pathogenesis.
Conclusions:
- Targeting lipoproteins and the renin-angiotensin-aldosterone system offers a promising therapeutic strategy for atherosclerotic cardiovascular disease.
- Further research into the molecular basis of atherosclerosis and risk factor contributions will yield new treatment avenues.
More Related Videos
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:30Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741